Cairo – Mubasher: Memphis Pharmaceutical and Chemical Industries earned EGP 42,000 in the first four months of 2016/17, lower 89.9% year-on-year from EGP 415,000, according to a bourse filing on Sunday.
Q1 profits also tumbled 96.5% year-on-year to EGP 42,000 from EGP 1.2 million, the company announced earlier.
The board of directors approved buying 1,000 kilograms of Ribavirin from Pharmaceutical Egyptian Company at a total of EGP 850.000 before tax.
The stock quote was higher 0.55% to EGP 11.01 by 11:25am CLT on Sunday.
